ATM/ATR
ATM (ataxia telangiectasia mutated) and ATR (ATM- and Rad3-related) are two PIKKs (phosphatidylinositol 3-kinase-like kinases) that regulate the DNA damage response (DDR) pathways.
Products for ATM/ATR
- Cat.No. Product Name Information
-
GC34999
(S)-Ceralasertib
(S)-AZD6738
(S)-Ceralasertib ((S)-AZD6738) is extracted from patent WO2011154737A1, Compound II, exhibits an IC50 of 2.578 nM.(S)-Ceralasertib is a potent and selective sulfoximine morpholinopyrimidine ATR inhibitor with excellent preclinical physicochemical and pharmacokinetic (PK) characteristics.(S)-Ceralasertib is developed improving aqueous solubility and eliminates CYP3A4 time-dependent inhibition. -
GC65327
ATM Inhibitor-5
M4076; ATM Inhibitor-5
ATM Inhibitor-5 [formula (1)] is a potent inhibitor of serine/threonine protein kinase ATM (extracted from patent WO2022058351A1). -
GC65514
ATR inhibitor 1
M1774; ATR inhibitor 1
ATR inhibitor 1 is a ATR inhibitor extracted from patent WO2015187451A1, compound I-l, has a Ki value below 1 ?Μ. -
GC74316
ATR kinase substrate peptide
ATR kinase substrate peptide (compound 45) is a potent and selective inhibitor of ATR (Ataxia Telangiectasia and Rad3 related) protein kinase (Ki=6 nM).
-
GC68707
ATR-IN-4
ATR-IN-4 is an effective ATR inhibitor. ATR-IN-4 inhibits the growth of human prostate cancer cells DU145 and human lung cancer cells NCI-H460, with IC50 values of 130.9 nM and 41.33 nM, respectively (excerpted from patent CN112142744A, compound 13).
-
GC19047
AZ32
AZ32 is an orally bioavailable and blood-brain barrier-penetrating ATM inhibitor with an IC50 of <6.2 nM for ATM enzyme, and an IC50 of 0.31 uM for ATM in cell.
-
GC64938
AZD-7648
AZD-7648 is a potent, orally active, selective DNA-PK inhibitor with an IC50 of 0.6 nM. AZD-7648 induces apoptosis and shows antitumor activity.
-
GC11593
AZD0156
ATM kinase inhibitor
-
GC19468
AZD1390
AZD1390 is a potent and selective ATM inhibitor
-
GC16941
AZD6738
Ceralasertib
AZD6738 (AZD6738) is an orally active and bioavailable inhibitor of ATR kinase with an IC50 of 1 nM. -
GC33420
BAY-1895344
Elimusertib
BAY-1895344 (BAY-1895344) is a potent, orally active and selective ATR inhibitor with an IC50 of 7 nM. BAY-1895344 has anti-tumor activity. BAY-1895344 can be used for the research of solid tumors and lymphomas. -
GC34374
BAY-1895344 hydrochloride
An ATR inhibitor
-
GC14526
CGK733
ATM/ATR Kinase Inhibitor
ATM/ATR inhibitor,potent and selective -
GC16489
CP-466722
ATM inhibitor,potent and reversible
-
GC25372
Elimusertib (BAY-1895344) hydrochloride
BAY-1895344 HCl
Elimusertib (BAY-1895344) hydrochloride is a potent, highly selective and orally available ATR inhibitor with an IC50 of 7 nM. -
GC69053
Elimusertib-d3
BAY 1895344-d3
Elimusertib-d3 (BAY 1895344-d3) is the deuterated form of Elimusertib-d3 (BAY 1895344). Elimusertib is an effective, orally available, selective ATR inhibitor with anti-tumor activity.
-
GC10196
ETP-46464
ATM Inhibitor III, ATR Inhibitor III
ATR inhibitor,potent and selective -
GC33404
KU 59403
KU 59403 is a potent ATM inhibitor, with IC50 values of 3 nM, 9.1 μM and 10 μM for ATM, DNA-PK and PI3K, respectively.
-
GC12054
KU-60019
KU60019;KU 60019
ATM kinase inhibitor,potent and selective -
GC13491
Mirin
Mirin is an inhibitor of Mre11-Rad50-Nbs1 (MRN) complex (IC50=12μM), which can inhibit the activity of MRE11-related exonuclease, and can inhibit the activation of MRN-dependent ATM. It is commonly used in the study of cancers related to DNA repair mechanisms.
-
GC64278
RP-3500
RP-3500; ATR inhibitor 4
RP-3500 (ATR inhibitor 4) is an orally active, selective ATR kinase inhibitor (ATRi) with an IC50 of 1.00 nM in biochemical assays. RP-3500 shows 30-fold selectivity for ATR over mTOR (IC50=120 nM) and >2,000-fold selectivity over ATM, DNA-PK, and PI3Kα kinases. RP-3500 has potent antitumor activity. -
GC64539
SKLB-197
SKLB-197 showed an IC50 value of 0.013 μM against ATR but very weak or no activity against other 402 protein kinases. It displayed potent antitumor activity against ATM-deficent tumors both in vitro and in vivo.
-
GC10293
VE-821
ATR Inhibitor IV
ATR kinase inhibitor
-
GC15337
VE-822
ATR inhibitor